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Abstract
Changes in bacterial composition of nasal microbiota may alter the host’s susceptibility to several infectious and allergic diseases
such as chronic rhinosinusitis and allergic rhinitis. The aim of this study was to evaluate the effects of 1-week administration of a
probiotic product, composed by a combination of Streptococcus salivarius 24SMBc and Streptococcus oralis 89a, on the nostril
microbiota. Differences in the nasal microbiota composition were investigated by using a next-generation sequencing approach.
A strong and significant decrease in Staphylococcus aureus abundance was detected immediately after the bacterial administra-
tion. Moreover, comparing the microbial networks of nostril microbiota before and 1 month after the end of treatment, we
detected an increase in the total number of both bacterial nodes and microbial correlations, with particular regard to the beneficial
ones. Furthermore, a less abundance of microbial genera commonly associated to potential harmful bacteria has been observed.
These results suggest a potential ability of S. salivarius 24SMBc and S. oralis 89a to regulate and reorganize the nasal microbiota
composition, possibly favoring those microorganisms that may be able to limit the overgrowth of potential pathogens.
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Introduction
The nasal microbiota is a complex microbial community,
composed of several different genera of aerobic and an-
aerobic microorganisms such as Staphylococcus spp.,
Corynebacterium spp., and Propionibacterium spp. [1].
Changes in the composition of nasal microbial population
may lead to the dysbiosis of nasal microbiota, thereby
favoring susceptibility to several inflammatory, infectious,
and allergic diseases such as chronic rhinosinusitis, aller-
gic rhinitis, and otitis [2–4]. Till now, systemic antibiotics
and anti-inflammatory therapies have been the primary
strategies used for the management of these pathological condi-
tions. However, extensive evidences suggest that antibiotics may
have limited efficacy [5]. Several studies demonstrated how com-
mensal α-hemolytic streptococci could be used to recover the
normal nasopharyngeal flora in children with recurrent otitis me-
dia [6–8]. These microorganisms may not only restore the bal-
ance between beneficial commensal bacteria and pathogenic spe-
cies but may also prevent development of antimicrobial resis-
tance due to the intensive use of antibiotics in the treatment of
nasal diseases [9]. The use of bacteria as a beneficial approach
has been a common practice that is already applied in different
fields, such as gastroenterology, gynecology, and dermatology
for treatment of functional disorders [10, 11].
Recently, a probiotic product based on the combination of
Streptococcus salivarius 24SMBc and Streptococcus oralis
89a has been developed for direct nasal administration
through a vaporizer for the prophylaxis and treatment of
chronic and recurrent infections of the upper airways. In this
paper, we present the effect of the administration of these two
streptococci on the nasal microbiota composition of healthy
subjects by evaluating changes in bacterial abundance and
microbial correlations in the microbiota network.
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Material and Methods
Enrollment of Subjects
Twenty healthy volunteers (11 males and 9 females, age 30 ±
5 and 32 ± 4, respectively) participated in this study. They
were informed in detail about the purpose of the study and a
written consent was obtained from each subject. Exclusion
criteria were antibiotic treatment in the previous 2 months
and use of any other medical device for treating nasal conges-
tion, such as nasal nebulizers or nasal irrigation devices, and
no pets in participant’s homes. The product was based on a
mixed dual-species of S. salivarius 24SMBc and S. oralis 89a
in a 98:2 ratio, suspended in a PEG/PPG copolymer (poly-
ethylene glycol chain bonded with poly-propylene glycol),
and pH 7.00-buffered isotonic solution. Probiotics were ad-
ministered with two bilateral spray inhalation into each ante-
rior nostril for 1 week, usually in the morning after showering
or personal care/washing.
Sample Collection and DNA Extraction
Sterile swabs in polypropylene tubes (Thermo Fisher, Italy)
were used for sampling the mucosal surface from the anterior
left nostril (depth 1 cm from the outer edge). From each par-
ticipant, four nasal swabs were collected as follows: before the
probiotic treatment, 1 week after the use of S. salivarius
24SMBc and S. oralis 89a, 2 weeks after the end of treatment,
and 1 month after the end of the probiotic administration.
Samples were rapidly frozen at − 80 °C until analysis which
began, in any case, within 48 h from sample collection. DNA
was extracted using the QIAamp DNA Mini Kit (Qiagen,
Italy).
Library Preparation and Sequencing
Partial 16S rRNA gene sequences were amplified from the
extracted DNA using the Ion 16S Metagenomics Kit (Life
Technologies, Italy) by two separate PCR reactions using
primer set V2, V4, V8 and V3, V6–7, V9. The PCR products
were processed to obtain the DNA library using the Ion Plus
fragment Library kit (Life Technologies, Italy) and the Ion
Xpress Barcode Adapters 1–16 kit (Life Technologies,
Italy). Adapter-ligated and nick-repaired DNAwas amplified
with the following steps: 1 cycle of 25 °C for 15, 72 °C for
5 min, followed by hold at 4 °C. For each step, a cleanup
procedure was performed using the Agencourt AMPure XP
DNA purification beads (Beckman Coulter Genomics,
Bernried, Germany). Each DNA library was eluted in low
Tris-EDTA buffer (Life Technologies, Italy). The final DNA
concentrations of the purified products were assayed using the
Qubit Fluorometer 2.0 (Thermo Fisher Scientific) according
to the manufacturer’s instructions. Each sample was adjusted
to 26 picomolar DNA concentration. Equal volumes of each
library were combined and processed with Ion PGM HI-Q
View OT2 Kit and One-Touch ES systems (Life
Technologies, Italy) according to the manufacturer’ instruc-
tions. Sequencing of the amplicon libraries was performed
on a 316 chip using the Ion Torrent Personal Genome
Machine (PGM) system and employing the Ion PGM Hi-Q
View Seq kit (Life Technologies, Italy). Base calling and run
demultiplexing were performed by Torrent Suite 5.1. (Life
Technologies, Italy), with default parameters. Data processing
was performed using Ion Reporter Software (Life
Technologies, Italy) which comprises a suite of bioinformatics
tools which automatically provide to add read labels in order
to mimic non-demultiplexed data for downstream analysis
and concatenating reads into one file. The reads were aligned
Fig. 1 Biodiversity data. The boxplot reported the variation before the probiotic intake (T1), 1 week after the probiotic treatment (T2), 2 weeks after the
probiotic intake (T3), and 1 month after the probiotic treatment (T4)
Fig. 2 Co-occurrence networks of nasal microbiota before and 1 month
after the end of probiotic intake. Node colors from bright to dark represent
interaction degrees from low to high of each node linked by other nodes.
The node labels are the bacterial genera OTU. A diamond shape was
selected to emphasize the node that has the greater number of leaves’
nodes linked to it which was defined as central hub. Gray dot lines
were used to set low values of Spearman’ s correlation instead edges
with 0.80 ≤ rs ≤ 0.98 were highlighted as solid lines. Positive
correlations were set in green, while negative ones were marked in red.
a The bacterial network before the probiotic administration was
constructed using a circular layout with 40 spatially co-occurring OTU
pairs and 121 total connections. Pseudomonas spp. was the central hub of
this map. Edges were all positive correlations. b The microbial network
1 month after the end of probiotic intake was constructed using 154 edges
and 48 spatially co-occurring OTU pairs; of these, 151 were all positive
correlations, while three connections were negative (with 0.60 ≤ rs ≤
0.79). Kocuria spp. was the central hub of this network as it has the most
number of connections
Probiotics & Antimicro. Prot. (2019) 11:1219–12261220
Probiotics & Antimicro. Prot. (2019) 11:1219–1226 1221
Probiotics & Antimicro. Prot. (2019) 11:1219–12261222
to the MicroSEQ ID library and to the Greengenes database to
achieve rapid and exhaustive bacterial identification with a
similarity coverage of 97%. The final output of Ion Reporter
Software was the identification and abundance of microorgan-
isms at the phylum, class, order, family, genus, and species
levels.
Statistical Analysis
Statistical analysis and the calculation of the biodiversity in-
dices (Shannon’s, Simpson’s, and Chao’s) were performed
using the Vegan 2.4.3 package for R Software V.3.3.1 for
Windows. Nonparametric tests based on the Kruskal–Wallis
and Wilcoxon rank-sum tests were used to determine the sig-
nificant differences in α diversity and microbial taxa.
Adjustment for multiple testing was evaluated with
Benjamini-Hochberg FDR correction; p values below 0.05
were considered statistically significant. The OTU abun-
dances were used to calculate an adjacency matrix based on
the Spearman’s correlation coefficient (rs) within each bacte-
rial genus to evaluate the strength of a linear association be-
tween different bacterial genera. Using Cytoscape _v3.4.0, the
adjacency matrix was integrated into a network model for
investigating the topological features of the microbial correla-
tions. The microbial network topology was evaluated consid-
ering an attribute circle layout and setting the node size on the
node’s degree: hubs with small sizes and light colors had low
values of node’s degree, hubs with largest number of connec-
tions with other microorganisms in the network were consid-
ered Bcentral nodes^ and highlighted by a diamond shape.
Conversely, nodes with less relevant number of connections
were defined as Bleaves^ nodes. Moreover, the strength of a
linear association between different bacterial genera was
underlined, selecting all edges with an absolute rs ≤ 0.60 at a
0.05 significance level. Low values of Spearman’s correlation
coefficient were highlighted for edges’ lines for as gray dot
lines; differently, connections with 0.80 ≤ rs ≤ 0.99,
corresponding to a very strong strength of a linear association,
were set as solid lines. Finally, positive correlations were
highlighted in green, while negative ones were marked in red.
Results and Discussion
During the experimental time course, no severe side ef-
fects were observed in any of the subjects. Immediately
after the end of probiotic administration, we observed a
significant reduction in the bacterial richness (Fig. 1).
This reduction could be due to a potential ability of the
two strains to displace the pathogens or to predominate
the unwanted microbial species, as previously described
for certain lactic acid bacteria that exert antiadhesive and
antimicrobial effects against S. aureus strains or other op-
portunistic pathogens colonizing the human intestinal tract
[12, 13]. This hypothesis was further suggested by the
inverse trend that we observed 1 month after the nasal
spray administration, in which the bacterial richness
tended to resemble the baseline value, and by the results
obtained with the microbial network analysis, in which an
increase in number of interactions could be observed, as
reported in Fig. 2. Moreover, comparing the microbial
maps of the nasal microbiota before and 1 month after
the probiotic treatment, we observed an increase in the
total number both of bacterial nodes and of microbial
correlations, especially considering the positive ones
(Fig. 2a, b, respectively). These results may suggest that
a reorganization of the nasal microbiota occurs after the
administration of the nasal spray. Assuming that the
highlighted correlations could reflect potential interaction
between different microorganisms, comparison of the mi-
crobial networks immediately after the probiotic intake
and 1 month after the end of administration evidenced
some interesting relationships (Fig. 3a, b, respectively).
For example, immediately after the probiotic intake, both
Veillonella spp. and Micrococcus spp. were identified as
central hubs (Fig. 3a) but 1 month after the end of the
probiotic intake, only Micrococcus spp. resulted as the
node with the highest number of connections in the bac-
terial network (Fig. 3b). Shukla et al. described Veillonella
spp. to be more prevalent in the nasal microbiota of urban
non-farmers, who are very similar to our healthy volun-
teers living in widely urbanized areas [14] and Periasamy
and Kolenbrander reported that Veillonella species had a
central role as early colonizers in establishing multispe-
cies oral biofilm communities [15]. Conversely, micrococ-
ci are common human commensals that colonize the skin,
the mucosa, and the oropharynx. Some species belonging
to the Micrococcus genus, such as Micrococcus luteus and
Micrococcus superificus, have been demonstrated to pos-
sess a strong inhibition ability towards peptidoglycan
Fig. 3 Co-occurrence networks of nasal microbiota immediately after the
probiotic intake and 1 month after the end of the nasal streptococci
administration. Node colors from bright to dark represent degrees from
low to high of each node linked by other nodes. The node labels are the
bacterial genera OTU. A diamond shape was selected to emphasize the
node that has the greater number of leaves’ nodes linked to it which was
defined as central hub. Gray dot lines were used to set low values of
Spearman’ s correlation instead edges with 0.80 ≤ rs ≤ 0.98 were
highlighted as solid lines. Positive correlations were set in green, while
negative ones were marked in red. a The network investigated
immediately after the probiotic intake was generated using 49 spatially
co-occurring OTU pairs and 455 total connections.Microbacterium spp.
was identified as the central hub and the edges are all positive correla-
tions. b The bacterial network 1 month after the end of the nasal strepto-
cocci administration was constructed using 154 edges and 48 spatially co-
occurring OTU pairs; of these, 151 were all positive correlations, while
three connections were negative (with 0.60 ≤ rs ≤ 0.79).Kocuria spp. was
the central hub of this network as it has the most number of connections
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biosynthesis and N-glycosylation of proteins [16, 17].
These properties could be responsible of a possible anti-
microbial activity of such Micrococcus species against
Gram-positive bacteria [17]. It could be speculated that
probiotic intake is able to favor the microbial interactions
of Veillonella spp. and Micrococcus spp., thereby causing
these taxa to play a key role in regulating the initial,
middle, and late colonizers of the nasal environment or
limiting the growth of potential pathogens, such as some
species of Staphylococcus, which strongly colonize the
nasal cavity. Interestingly, after 1 week of probiotic ad-
ministration, there was a significant increase in
Staphylococcus spp. abundance (Fig. 4a). However,
studying this genus at a deeper taxa level, we observed
that the bacterial load of S. aureus was subjected to a
strong and significant decrease immediately after the pro-
biotic intake (Fig. 4b), especially when compared to that
of coagulase-negative staphylococci. A recent study ana-
lyzed the nasal staphylococci isolated by bacterial culture
techniques for antimicrobial activities and reported that
these bacteria produced antimicrobials at an unexpectedly
high rate (86%) against numerous nasal bacteria [18].
Staphylococcus epidermidis is known to secrete high
levels of extracellular serine protease (Esp), which limits
S. aureus nasal colonization, probably by degrading its
surface adhesins or epithelial protein ligands [18].
Similarly, nasal Staphylococcus lugdunensis can synthe-
size an antibacterial compound known as lugdunin that
inhibits and counteracts the growth of S. aureus [19]. In
addition, Staphylococcus xylosus , Staphylococcus
warneri, and Staphylococcus hominis have been described
as bacteriocin-producing species as they are capable of
producing antimicrobial molecules actively in the nasal
microbiota [18–20].
Competition by antibiosis may also be one mechanism by
which S. salivarius 24SMBc and S. oralis 89a may carry out
their probiotic activity. Bowe et al. reported the in vitro inhi-
bition of Propionibacterium acnes through a bacteriocin-like
inhibitory substance (BLIS-like substance) produced by a
strain of S. salivarius [21]. A strong bacteriocin-like inhibitory
activity has also been demonstrated for S. salivarius 24SMB
(DSM 23307), with an inhibitory spectrum mainly targeted
against Streptococcus pneumoniae and some clinical isolates
of Streptococcus pyogenes [22]. Moreover, S. oralis 89a ge-
nome harbors genes encoding for the bacteriocin Colicin V
and for tolerance to Colicin E2 [23]. These evidences would
lead to hypothesize that S. salivarius 24SMBc and S. oralis
89a may mediate bacterial species competition in the nasal
cavity through distinct direct or indirect mechanisms.
Our data underline the importance to better investigate the
specific pathways that regulate the stability or resilience of a
bacterial ecosystem to develop strategies of ecological modula-
tion, especially in individualswith dysbiosis or whosemicrobiota
is characterized by a low biodiversity. Investigating the bacterial
correlations, based on the microbial abundances, the present
study has emphasized the need to integrate the study of the mi-
crobial network analysis methods to have a complete and clear
characterization of the bacterial populations, as already stated in a
previous study [24]. One limitation of this study is the lack of a
control group or of a control treatment in the enrolled subjects, to
better evaluate the effects on nasal microbiome of probiotics’
administration. This choice was mainly due to the need to ex-
clude allergic subjects and those who did not have consumed
antibiotics and probiotics in the period before the study. At the
same way, the need of a long washout period between adminis-
tration of control and probiotic preparations prompted us to
choose a pre-dosing sample before administration of the tested
probiotics.
Moreover, the study of bacterial interactions by the con-
struction of microbial network is still a little-researched field.
Therefore, it is likely that there are still a lot of gaps in the
knowledge that need to be filled and that could be useful to
support many of the hypothesis arose by the interpretation of
the results obtained. For these reasons, the results of the pres-
ent study need to be taken with considerable caution. To better
understand the meaning of the correlations here highlighted,
we are currently investigating, bymeans of in vitro studies, the
ability of S. salivarius 24SMB and S. oralis 89a to interfere
with adhesion and biofilm formation of typical upper respira-
tory tract pathogens. Further investigations could also concern
the constructions and analysis of functional networks that,
based on producing function-taxonomy link, can better de-
scribe the association between the microbial community and
its functions. In the future, contextualizing discrete functions
of a microbial network will contribute to elucidate the role that
specific microbes play on host’s health as well as the potential
molecular mechanisms involved in the microbiota-host inter-
action. A recent study has highlighted that the nasal
microbiome of healthy dairy farmers has a greater biodiversity
than that of non-farmers living in urban settings, as the farmer
individuals are exposed to a more complex microbial environ-
ment [14]. Indeed, the interactions with the surrounding envi-
ronment play a pivotal role in enriching the commensal mi-
crobiota and enhancing its interaction with the host’s immune
system. For this reason, the use of health-associated microor-
ganisms, such as alpha-hemolytic streptococci, might promote
Fig. 4 Significant variation in microbial abundances. The histograms
reported only the significant variation before the probiotic intake (T1),
1 week after the probiotic treatment (T2), 2 weeks after the probiotic
intake (T3), and 1 month after the probiotic treatment (T4). In
particular, the panel a shows the bacterial genera that are significantly
different in the nasal microbiota composition before probiotic
administration and after 1 week of treatment with Streptococcus
salivarius 24SMB and Streptococcus oralis 89a (p ≤ 0.05). Differently,
panel b reports only the abundance of Staphylococcus species
significantly changing during time are reported (p ≤ 0.05)
Probiotics & Antimicro. Prot. (2019) 11:1219–1226 1225
beneficial modulations, especially for those individuals living
in urban areas where a decreased microbial biodiversity has
been associated with an increased incidence of allergic and
inflammatory disorder [25]. In conclusion, our preliminary
results highlighted the ability of S. salivarius 24SMBc and
S. oralis 89a to influence the nasal microbiota composition,
even though all the observed bacterial changes were not fully
characterized. However, a reduction of potential harmful bac-
teria is an important feature of the two probiotic streptococcal
strains and indicates a promising use for future applications in
the clinical field.
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